Building on the initial findings, we extended our investigation to determine the synergistic effect of ZrTCP@siFOXK2 NPs with metformin, given that prior studies confirmed the ability of metformin to enhance the inhibitory effect of FOXK2 siRNA on ovarian cancer cells. The gene discussed is FOXK2; the disease is ovarian cancer.